Ceftrimax Injection

Ceftriaxone 1g 2g IV 1g IM 500 mg IV&IM Injection

Ceftrimax 500 mg IM injection: Each vial contains sterile Ceftriaxone Sodium USP equivalent to Ceftriaxone 500 mg.
Ceftrimax 500 mg IV injection: Each vial contains sterile Ceftriaxone Sodium USP equivalent to Ceftriaxone 500 mg.
Ceftrimax 1 g IM injection: Each vial contains sterile Ceftriaxone Sodium USP equivalent to Ceftriaxone 1 g.
Ceftrimax 1 g IV injection: Each vial contains sterile Ceftriaxone Sodium USP equivalent to Ceftriaxone 1 g.
Ceftrimax 2 g IV injection: Each vial contains sterile Ceftriaxone Sodium USP equivalent to Ceftriaxone 2 g.

Ceftrimax is indicated for the treatment of the following major infections when caused by susceptible organisms:
1. Renal and urinary tract infections
2. Lower respiratory tract infections, particularly pneumonia
3. Gonococcal infections
4. Skin and soft tissue, bone and joint infections
5. Bacterial meningitis
6. Serious bacterial infections e.g. septicemia
7. ENT infections
8. Infections in cancer patients
9. Prevention of postoperative infection
10. Preoperative prophylaxis of infections associated with surgery
11. Typhoid fever

Ceftrimax (ceftriaxone) can be administered either intravenously or intramuscularly.
Adults: The usual adult daily dose is 1-2 g once daily, (or twice daily in equally divided doses) depending on the type and severity of infection. The daily dose may be increased, but should not exceed 4 g. For preoperative use (surgical prophylaxis), a single dose of 1 g administered intravenously 0.5-2 hours before surgery is recommended. In patients with impaired renal function, there is no need to reduce the dosage of Ceftrimax provided liver function is intact.
In patients with liver damage, there is no need for the dosage to be reduced provided renal function is intact.
Gonorrhea: For the treatment of gonorrhea, a single intramuscular dose of 250 mg is recommended.
Children under 12 years: The recommended total daily dose is 50 to 75 mg/kg once daily (or twice daily in equally divided doses). In severe infections, up to 80 mg/kg body weight daily may be given. The total daily dose should not exceed 2 g.
In the treatment of meningitis, the initial dose of 100 mg/kg body weight (not to exceed 4 g daily) once daily (or twice daily in equally divided doses), is recommended. As soon as the causative organism has been identified and its sensitivity, the doses can be reduced accordingly. The usual duration of therapy in meningitis is 7 to 14 days.

Related Products

Esover

Details

Prazover

Details